https://scholars.lib.ntu.edu.tw/handle/123456789/523281
標題: | Highlights of the 2019 Japanese Society of Hypertension Guidelines and perspectives on the management of Asian hypertensive patients | 作者: | Hoshide S. Kario K. Tomitani N. Kabutoya T. Chia Y.-C. Park S. Shin J. Turana Y. Tay J.C. Buranakitjaroen P. Chen C.-H. Nailes J. Minh H.V. Siddique S. Sison J. Soenarta A.A. Sogunuru G.P. Sukonthasarn A. Teo B.W. Verma N. Zhang Y. TZUNG-DAU WANG Wang J.-G. |
關鍵字: | elderly population; guideline; home blood pressure; hypertension | 公開日期: | 2020 | 出版社: | Blackwell Publishing Inc. | 卷: | 22 | 期: | 3 | 起(迄)頁: | 369-377 | 來源出版物: | Journal of Clinical Hypertension | 摘要: | Unlike other international guidelines but in accord with the earlier Japanese Society of Hypertension (JSH) guidelines, the 2019 JSH guidelines (“JSH 2019”) continue to emphasize the importance of out-of-office blood pressure (BP) measurements obtained with a home BP device. Another unique characteristic of JSH 2019 is that it sets clinical questions about the management of hypertension that are based on systematic reviews of updated evidence. JSH 2019 states that individuals with office BP?140/90?mm?Hg do not have normal BP. The final decisions regarding the diagnosis and treatment of hypertension should be performed based on out-of-office BP values together with office BP measurements. For hypertensive adults with comorbidities, the office BP goal is usually <130/80?mm?Hg and the home BP goal is <125/75?mm?Hg. Recommendations of JSH 2019 would be valuable for not only Japanese hypertensive patients but also Asian hypertensive patients, who share the same features including higher incidence of stroke compared with that of myocardial infarction and a steeper blood pressure-vascular event relationship. ? 2019 Wiley Periodicals, Inc. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077889100&doi=10.1111%2fjch.13763&partnerID=40&md5=1a059afdab30d6ad14d3d1a732559c42 https://scholars.lib.ntu.edu.tw/handle/123456789/523281 |
ISSN: | 1524-6175 | DOI: | 10.1111/jch.13763 | SDG/關鍵字: | angiotensin receptor antagonist; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; diuretic agent; olmesartan; antihypertensive agent; Asian; blood pressure measurement; blood pressure regulation; cardiovascular mortality; cerebrovascular accident; clinical feature; comorbidity; elderly care; evidence based medicine; heart infarction; human; hypertension; hypertensive patient; Japanese (people); medical society; patient care; practice guideline; priority journal; quality of life; renin angiotensin aldosterone system; Review; adult; blood pressure; drug effect; hypertension; Japan; sphygmomanometer; Adult; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Humans; Hypertension; Japan; Sphygmomanometers |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。